Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei Keda Biotechnology is a Chinese life sciences company that specializes in the research, development, and manufacturing of molecular biology reagents and diagnostic kits. Established in 2001 and maintaining a strong technical relationship with the University of Science and Technology of China (USTC), the company provides essential tools for genetic engineering, protein research, and clinical diagnostics. Its product portfolio includes DNA/RNA purification kits, PCR reagents, restriction enzymes, and biochemical assay kits. The company primarily serves the academic research community, healthcare providers, and biotechnology firms within China. It is recognized for its high-quality standards and its role in supporting domestic scientific research infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 合肥科大生物技术.